islet il 1β immunoreactivity Search Results


interleukin-1β receptor  (Matos labs)
90
Matos labs interleukin-1β receptor
Interleukin 1β Receptor, supplied by Matos labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/islet+il+1%CE%B2+immunoreactivity/interleukin+1%CE%B2+receptor/pmc02189996-45-33-45
Average 90 stars, based on 1 article reviews
interleukin-1β receptor - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
interleukin 1 beta il 1β  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology interleukin 1 beta il 1β
Interleukin 1 Beta Il 1β, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/islet+il+1%CE%B2+immunoreactivity/IL-1%CE%B2/10__1007_slash_s44411___026___00503___7-56-2-13
Average 96 stars, based on 1 article reviews
interleukin 1 beta il 1β - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
islet il 1β immunoreactivity  (ProSci Incorporated)
93
ProSci Incorporated islet il 1β immunoreactivity
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Islet Il 1β Immunoreactivity, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/islet+il+1%CE%B2+immunoreactivity/Interleukin+1b+Recombinant+Protein/pmc05860832-188-15-20
Average 93 stars, based on 1 article reviews
islet il 1β immunoreactivity - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
il 1β  (Cusabio)
96
Cusabio il 1β
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Il 1β, supplied by Cusabio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/islet+il+1%CE%B2+immunoreactivity/IL6/us10780138-58-10-26
Average 96 stars, based on 1 article reviews
il 1β - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
interleukin-1β  (Neuropharm Ltd)
90
Neuropharm Ltd interleukin-1β
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Interleukin 1β, supplied by Neuropharm Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/islet+il+1%CE%B2+immunoreactivity/interleukin+1%CE%B2/pmc05559763-906-25-0
Average 90 stars, based on 1 article reviews
interleukin-1β - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human il-10 mpxhcyto-60k-04  (Merck KGaA)
90
Merck KGaA human il-10 mpxhcyto-60k-04
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Human Il 10 Mpxhcyto 60k 04, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/islet+il+1%CE%B2+immunoreactivity/milliplex+map+human+cytokine+chemokine+panel/pmc03298003-608-3-19
Average 90 stars, based on 1 article reviews
human il-10 mpxhcyto-60k-04 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
anti il 1β  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc anti il 1β
IHC for <t>insulin,</t> <t>IL-1β,</t> and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.
Anti Il 1β, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/islet+il+1%CE%B2+immunoreactivity/IL-1beta+Mouse+mAb/pm35749835-76-5-7
Average 95 stars, based on 1 article reviews
anti il 1β - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

Image Search Results


IHC for insulin, IL-1β, and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.

Journal: Diabetes Care

Article Title: Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure

doi: 10.2337/dc17-1387

Figure Lengend Snippet: IHC for insulin, IL-1β, and amyloid in subjects with and without CF. Representative staining of pancreas specimens from subjects in non-CF control (A–D), CF-no DM (E–H), and CFRD (I–L) groups, identifying islet β-cells using IHC for insulin (brown in A, E, and I and red in D, H, and L), IL-1β (brown; images shown from two subjects per group in B and C, F and G, and J and K), and amyloid (visualized by thioflavin S [ThioS] histochemistry; green in D, H, and L). Quantitation of the proportion of islets positive for IL-1β (M) and amyloid (N). Islet IL-1β positivity was increased in CF-no DM and CFRD subjects compared with age-matched non-CF control subjects, whereas islet amyloid deposition was only increased in CFRD subjects. Scale bar = 50 µm.

Article Snippet: Islet IL-1β Immunoreactivity Is Seen Even in Very Young Subjects With CF We next analyzed islet IL-1β immunoreactivity (using the ProSci antibody) in the subset of pediatric CF subjects <10 years of age, the currently recommended age to begin screening CF patients for CFRD with oral glucose tolerance tests ( 5 ).

Techniques: Staining, Control, Quantitation Assay

Subject characteristics and islet morphometric analyses in individuals with CF, subdivided according to diabetes and lung transplant status

Journal: Diabetes Care

Article Title: Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure

doi: 10.2337/dc17-1387

Figure Lengend Snippet: Subject characteristics and islet morphometric analyses in individuals with CF, subdivided according to diabetes and lung transplant status

Article Snippet: Islet IL-1β Immunoreactivity Is Seen Even in Very Young Subjects With CF We next analyzed islet IL-1β immunoreactivity (using the ProSci antibody) in the subset of pediatric CF subjects <10 years of age, the currently recommended age to begin screening CF patients for CFRD with oral glucose tolerance tests ( 5 ).

Techniques: